Atlas Trials

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

Clinical trial NCT01258439 · COMPLETED

Trial details

NCT number
NCT01258439
Sponsor
St Vincent's Hospital, Sydney
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIVCardiovascular Disease
Start date
2010-11-01
Primary completion
2014-07-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.